Traynor Capital Management Inc. Sells 191 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Traynor Capital Management Inc. lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 18.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 858 shares of the healthcare conglomerate’s stock after selling 191 shares during the quarter. Traynor Capital Management Inc.’s holdings in UnitedHealth Group were worth $434,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Independent Wealth Network Inc. lifted its position in UnitedHealth Group by 27.8% during the fourth quarter. Independent Wealth Network Inc. now owns 464 shares of the healthcare conglomerate’s stock worth $235,000 after purchasing an additional 101 shares during the period. Wesbanco Bank Inc. lifted its holdings in shares of UnitedHealth Group by 4.8% during the 4th quarter. Wesbanco Bank Inc. now owns 51,868 shares of the healthcare conglomerate’s stock worth $26,238,000 after acquiring an additional 2,365 shares during the period. Sharp Financial Services LLC raised its position in UnitedHealth Group by 11.0% during the fourth quarter. Sharp Financial Services LLC now owns 885 shares of the healthcare conglomerate’s stock valued at $447,000 after purchasing an additional 88 shares in the last quarter. Phillips Wealth Planners LLC boosted its holdings in shares of UnitedHealth Group by 4.4% in the 4th quarter. Phillips Wealth Planners LLC now owns 2,767 shares of the healthcare conglomerate’s stock valued at $1,441,000 after purchasing an additional 117 shares in the last quarter. Finally, Kelleher Financial Advisors lifted its position in shares of UnitedHealth Group by 1.3% during the 4th quarter. Kelleher Financial Advisors now owns 3,315 shares of the healthcare conglomerate’s stock worth $1,677,000 after buying an additional 43 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

UNH has been the subject of a number of research reports. Oppenheimer increased their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Barclays lowered their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday. Royal Bank of Canada reduced their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Trading Down 1.1 %

UNH opened at $519.08 on Thursday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a fifty day moving average price of $545.26 and a two-hundred day moving average price of $564.10. The company has a market cap of $477.70 billion, a P/E ratio of 33.49, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $5.83 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.75 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.62%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.